Empower Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Buy |
5,022
+47
| +0.9% | +$5.21K | ﹤0.01% | 311 |
|
|
2025
Q1 | $557K | Sell |
4,975
-1,169
| -19% | -$131K | ﹤0.01% | 310 |
|
|
2024
Q4 | $568K | Sell |
6,144
-1,392
| -18% | -$129K | ﹤0.01% | 308 |
|
|
2024
Q3 | $632K | Sell |
7,536
-3,420
| -31% | -$287K | ﹤0.01% | 286 |
|
|
2024
Q2 | $752K | Buy |
10,956
+3,581
| +49% | +$246K | ﹤0.01% | 252 |
|
|
2024
Q1 | $540K | Sell |
7,375
-2,418
| -25% | -$177K | ﹤0.01% | 293 |
|
|
2023
Q4 | $793K | Buy |
9,793
+2,203
| +29% | +$178K | ﹤0.01% | 247 |
|
|
2023
Q3 | $569K | Buy |
7,590
+91
| +1% | +$6.82K | ﹤0.01% | 282 |
|
|
2023
Q2 | $578K | Sell |
7,499
-282
| -4% | -$21.7K | ﹤0.01% | 287 |
|
|
2023
Q1 | $648K | Buy |
+7,781
| New | +$648K | ﹤0.01% | 275 |
|